Per ERS 2017 Bronchiectasis Guidelines — this patient with BSI 9 (severe), chronic Pseudomonas colonization, and 3-4 exacerbations/year is a high-priority case: **1. Long-term Inhaled Antibiotics (first choice for chronic Pseudomonas):** - **Colistimethate sodium (Promixin/Colobreathe):** Approved in EU for bronchiect…
CPAP non-compliance is a common clinical challenge. Here's the evidence-based stepwise approach for severe OSA (AHI 55): **Step 1: Optimize CPAP Before Switching (AASM 2024)** - Telehealth adherence counseling (motivational interviewing) - Auto-titrating CPAP (APAP): Automatically adjusts pressure 4-20 cmH2O, better t…
Per ESC/ERS 2022 PAH Guidelines — this question is excellently framed. **Risk Stratification First (ESCRHS 2022):** This patient's risk profile: - WHO FC II-III (intermediate) - 6MWD 340m (low-intermediate) - mPAP 48, PVR 8 (high) - TAPSE 14mm (low, RV dysfunction) - No vasoreactivity → NOT a candidate for calcium cha…
Per ATS/ERS/WASOG 2023 Sarcoidosis Management Guidelines: **For this patient (Stage II, asymptomatic, FVC 75%, DLCO 62%):** The short answer is: OBSERVE, do not start steroids yet. **Indications to START Systemic Corticosteroids in Pulmonary Sarcoidosis:** 1. Progressive pulmonary involvement (FVC declining >10% per …
Per BTS 2023 Pleural Disease Guidelines for PSP: **Size Assessment:** - BTS uses a simplified 2-zone approach: >2cm visible rim on CXR at hilum level = significant/large pneumothorax. - This patient has 20% collapse → moderate PSP. **BTS 2023 Algorithm for PSP:** 1. **Hemodynamically stable + breathless or large (>2c…
This is a classic TB pleural effusion presentation. Here's the systematic approach: **Light's Criteria Confirmation:** This is an exudate because: - Pleural LDH/Serum LDH = 280/190 = 1.47 (>0.6) ✓ - Pleural protein/Serum protein = 4.2/6.5 = 0.65 (>0.5) ✓ **ADA (Adenosine Deaminase) Interpretation:** - ADA >40 U/L in …
Per ATS/ERS/JRS/ALAT 2022 IPF Diagnostic Guidelines — this is well answered: **Is surgical lung biopsy (SLB) needed for typical UIP on HRCT?** NO — a typical UIP pattern on HRCT in the correct clinical context is sufficient for diagnosis without biopsy. ATS/ERS 2022 guidelines state that typical UIP pattern (bilateral…
Per GINA 2023, here's the step-up strategy for uncontrolled moderate-severe asthma: **Step 3 to Step 4 Escalation (your patient):** Her profile — FeNO 48 ppb (high, ≥50 indicates eosinophilic T2 airway inflammation), blood eosinophils 450/uL, 2 exacerbations/year, FEV1 68% — strongly suggests T2-high eosinophilic asth…
Excellent question on a commonly encountered clinical dilemma. Here's the ESC 2019 PE guideline-based approach: **PESI vs sPESI — Practical Use:** - sPESI (simplified) is preferred for bedside use: 1 point each for age >80, cancer, cardiopulmonary disease, HR ≥110, SBP <100, SpO2 <90%. Score 0 = low risk; ≥1 = high ri…
This is a critical scenario requiring rapid decision-making. Here's how to approach NIV vs invasive ventilation in acute COPD exacerbation: **Indications for NIV (BiPAP) — GOLD 2023 / BTS guidelines:** - Moderate-severe hypercapnic respiratory failure: pH 7.25–7.35, PaCO2 >45 mmHg - Respiratory rate >25/min despite in…
This presentation is HYPERTENSIVE URGENCY (not emergency), because there is no evidence of acute target-organ damage (no papilledema, no AKI, no troponin rise, no focal neuro deficits, no aortic dissection features). Key distinction: - Hypertensive EMERGENCY = severely elevated BP + acute end-organ damage (hypertensiv…
For hemodynamically stable new-onset AF (<48 hours duration), either rate control or rhythm control is acceptable. Key decision points: IMMEDIATE ELECTRICAL CARDIOVERSION is indicated when: - Hemodynamic instability (hypotension, acute pulmonary edema, severe chest pain) - Pre-excitation (WPW + AF) — IV amiodarone/dig…
The 2022 AHA/ACC Heart Failure Guidelines recommend initiating all four pillars of GDMT simultaneously or in rapid succession rather than sequential up-titration. Practical sequencing for a stable outpatient like this: 1. Continue beta-blocker (metoprolol succinate already started — continue and uptitrate to target do…
Per ACC/AHA 2013 STEMI guidelines, primary PCI is the preferred reperfusion strategy if door-to-balloon (D2B) time is ≤90 min (or ≤120 min from first medical contact). Fibrinolysis is preferred when: (1) PCI is unavailable at the presenting facility, AND (2) expected D2B time exceeds 120 minutes from first medical cont…